Mr. Anderson is a member of Kohlberg’s Investment Committee and is responsible for leading the execution and monitoring of certain new and existing Kohlberg investments. Mr. Anderson joined Kohlberg in 1998 and was named a Partner in 2005.
Prior to joining the Firm, Mr. Anderson was with Warburg Dillon Read L.L.C. He is a member of the board of directors for Cadence; K2-MDV; PCI Pharma Services; Spinal Elements and Trinity Life Sciences.
Mr. Anderson received a B.A. from Princeton University.